Simplify Life with Omnipod® 5
Meet Omnipod 5
Omnipod 5 automatically adjusts your insulin delivery every 5 minutes without tubes or manual guesswork. It's the first and only tubeless Automated Insulin Delivery System (AID) that integrates with leading sensor brands, for people living with type 1 diabetes, aged 2 and above in Canada. It is recommended that anyone interested in learning more about the Omnipod 5 System speak with their healthcare provider (HCP) to discuss if they are suitable for the product.
Get Started by learning about your coverage for Omnipod 5
How It Works
Every five minutes the sensor reports glucose levels to the Pod. Technology built into the Pod automatically adjusts your insulin:
- when glucose levels are dropping, insulin delivery automatically decreases or pauses.
- when glucose levels are rising, insulin delivery automatically increases.
One System. 3 Simple Parts.
Continuous Control.
Screen image is an example, for illustrative purposes only. Sensors are sold separately and require a separate prescription.
Omnipod 5 Controller
Take control of the system with the Omnipod 5 Controller. Monitor and control the Pod's operations using Bluetooth® wireless technology.
Pod
Tubeless, wearable, and waterproof‡, the Pod, with built-in technology, sits on the body and automatically adjusts insulin delivery for up to 3 days (72 hours).
Sensor
In Automated Mode, the system records automated insulin delivery and corresponding sensor glucose values every 5 minutes, so you can get real-time data§ without the fingerpricks†. Compatible sensors are sold separately and require a separate prescription.
When paired with a compatible sensor, Omnipod 5 continuously delivers insulin to keep you in range, day and night1,2. Learn more about compatible CGMs/sensors here
Proven to help you stay in range1,2
Omnipod 5 is designed to help keep your glucose levels steadier throughout the day and night by automatically adjusting insulin delivery.
What this means for you:
Shown to increase Time in Range1,2
Over 80% Time in Range with optimized settings*
Helps protect from lows
In a real-world setting, Omnipod 5 users spent 1% time in hypoglycaemia3
Helps correct highs
Reduced time in hyperglycaemia by 33% in children4 and 24% in adults and adolescents5
Why people choose Omnipod 5
Omnipod 5 helps you spend more time living life and less time thinking about diabetes. Unlike other insulin pumps, Omnipod 5 requires no tubing and can be worn discreetly under clothing.
Tubeless and waterproof†
No tubes, no tangles. Wear your Pod in the shower, swimming pool or lake†!
Automated insulin delivery
Adjusts insulin delivery every 5 minutes, so you don't have to
No more multiple daily injections
It can replace over a thousand injections a year.6
Real reviews from real users:
Learn more about how Omnipod 5 has changed the lives of Canadian users. Watch video testimonials and more from Omnipod users on YouTube
Alaiza, 4 and Mom Melissa
Alaiza (4) is an energetic and independent young lady, living with T1D since 13 months old. Her mom Melissa describes the difference in Alaiza and in their family’s life since starting Omnipod 5.
River, 9 and Mom Liana
River (9) and his family share their experience with type 1 diabetes, from the uncertainty of diagnosis to finding a new normal. Through family moments and honest conversations, River, his little brother Asher, mom Liana, and his dad Jesse reflect on what those early days felt like, the challenges they faced, and how life gradually became more manageable over time.
Max Domi, 30,
Professional Hockey Player
For Max Domi, the dream of playing professional hockey never wavered, and living with type 1 diabetes has been part of that path. He shares how Omnipod 5 fits into his daily insulin management routine.
Real results from real users:
90%
agree that the system is easy to use7
92%
said it gives them peace of mind8
90%
agree bolusing with Omnipod 5 is as quick as sending a text9
Start your journey with Omnipod® 5
Take the first step toward tubeless, automated insulin delivery. Whether you want to try it, see it, or speak with someone about it, you’ll find the option that suits you best.
Learn more about coverage in your province or with your private insurer and start your Omnipod 5 order
The Pod Experience Kit (PEK) contains a non-functioning adhesive Pod with no needle so you can try the Pod on and wear it for 3 days to get a feel for living your daily life with a Pod.
Register for a Pod 101 webinar session to learn more about Omnipod 5 from an Omnipod Specialist + ask any questions you might have!
Features that make everyday life easier
SmartBolus Calculator and Custom Foods: simplify mealtime math
The SmartBolus Calculator uses your sensor glucose value and trend to calculate insulin doses. Custom Foods builds on this by letting you save up to 50 meals, foods, or snacks you eat often. Together, they reduce the need for complex calculations and make repeat meals, kids’ lunches, and busy days quicker and easier to manage.
Activity Feature: support when life gets active
When enabled, our Activity feature reduces insulin delivery when glucose typically goes low, like when exercising.
Ideal for:
- exercise
- sleepovers
- sick days
- times when you simply want reduced insulin delivery
†Fingerpricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
‡The Pod has an IP28 rating for up to 7.6 metres (25 feet) for up to 60 minutes. The Controller is not waterproof. Please consult sensor manufacturer user guide for sensor waterproof rating.
§Shah VN, et al. Diabetes Technol and Ther. 2018;20(6).
¶The PEK includes a non-functioning, needle-free Pod which allows you to experience how it feels to wear a Pod. The demo Pod is for demonstrative purposes only and is not able to deliver insulin. This PEK is available only to people with type 1 diabetes who are on a current insulin treatment (e.g., multiple daily injections or insulin pump therapy). People with type 2 diabetes are not eligible to receive a PEK unless they reside in British Columbia. The PEK does not include a physical Omnipod 5 Controller or the Omnipod DASH PDM.
A1C, glycated hemoglobin (HbA1c); TIR, time in range.
1. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Average time with low blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 2.9% vs. 1.3%; 2.2% vs. 1.8%. Study funded by Insulet.
2. Sherr JL, et al. Diabetes Care. 2022;45(8):1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system. Mean HbA1c as measured in very young children, ST vs. Omnipod 5 use:7.4% vs 6.9% or 57 mmol/ml vs. 53 mmol/mol; (p<0.0001). Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, p<0.0001. Mean time >10.0 mmol/L or >180mg/dL (12AM-<6AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 38.4% vs. 16.9%, p<0.0001, respectively. Mean time >10.0 mmol/L or >180mg/dL (6AM-<12AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 39.7% vs. 33.7%, P<0.0001, respectively. Mean time <3.9 mmol/L or <70 mg/dL (12AM-<6AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 3.41% vs. 2.13%, p=0.0185. Mean time <3.9 mmol/L or <70 mg/dL (6AM-<12AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 3.44% vs. 2.57%, p=0.0799. Study funded by Insulet.
3. Forlenza G, et al. Diabetes Technol Ther. 2024. 26(8):514-525. Retrospective analysis of real-world data from 69,902 individuals with type 1 diabetes using Omnipod 5 had a median time below range (<3.9 mmol/L or <70 mg/dL) of 0.97%. Omnipod 5 results based on users with ≥90 days CGM data, ≥75% of days with ≥220 readings available.
4. Study in 112 people with T1D aged 6 – 13.9 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose (from CGM): standard therapy = 45.3%, 3-month Omnipod 5 = 30.2%. Brown S. et al. Diabetes Care (2021).
5. Brown S. et al. Diabetes Care (2021) Study in 128 people with T1D aged 14 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose (from CGM): standard therapy = 32.4%, 3-month Omnipod 5 = 24.7%. Study funded by Insulet.
6. Chiang et al. Diabetes Care. 2014:37:2034-2054. 1,643 insulin injections in a year based on people with type 1 diabetes on multiple daily injections taking ≥ 3 bolus and 1-2 basal injections/day (~4.5/day).
7. Insulet Data on File. OP5-003 Clinical Study Report. 2024. A 13-week randomised controlled trial conducted among 194 adults (age 18-70 years) with type 1 diabetes in France and the U.S., comparing the safety and effectiveness of the Omnipod 5 Automated Insulin Delivery (AID) System versus conventional non-AID pump therapy and CGM (control). At 13-weeks of Omnipod 5 use 130 participants were asked via a System Usability Survey (SUS) if the system was easy to use. 71.5% of participants strongly agreed and 19.2% agreed. RF-112024-00029
8. 2025 Customer Survey of U.S. adults with Type 1 diabetes (n=1230), 92% agreed Omnipod 5 gives them peace of mind. RF-082025-00063
9. 2025 Customer Survey of U.S. adults with Type 1 diabetes, n=1230, 90% agreed bolusing with Omnipod 5 is as quick as sending a text. RF-082025-00063